表紙
市場調查報告書

液態切片 (液態生物檢體)的美國市場

Liquid Biopsy | Medtech 360 | Market Insights | United States

出版商 Decision Resources Group - Medtech 商品編碼 933299
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
液態切片 (液態生物檢體)的美國市場 Liquid Biopsy | Medtech 360 | Market Insights | United States
出版日期: 2020年03月31日內容資訊: 英文
簡介

美國的液態切片檢驗 (液態生物檢體) ,由於美國朝高齡人口,價值為基礎的醫療的轉移,非侵入性,低成本等,預計2028年急速成長。

本報告提供美國的液態切片 (液態生物檢體) 市場相關調查分析,全面的資料,加上市場現狀,10年預測相關之系統性資訊。

目錄

美國

摘要

摘要整理

更新履歷

液態切片 (液態生物檢體) 市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
  • 競爭亮點
  • 市場佔有率排行榜
  • 競爭要素與策略
  • 市場發展

篩檢檢驗市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
  • 競爭亮點
  • 市場佔有率排行榜
  • 競爭要素與策略

治療選擇檢驗市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
  • 競爭亮點
  • 市場佔有率排行榜
  • 競爭要素與策略

監測檢驗市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
  • 競爭亮點
  • 市場佔有率排行榜
  • 競爭要素與策略

附錄

目錄
Product Code: M360LB0001

The US market for liquid biopsy tests will exhibit rapid growth through 2028, driven by the aging US population, the shift toward value-based health care, the noninvasive nature of liquid biopsy tests, and the low cost of administration of liquid biopsies relative to tissue-based biopsy testing. These factors will fuel strong uptake of newer tests with improved diagnostic accuracy and reduced turnaround time.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for liquid biopsies in the US across a 10-year period.

The use of liquid biopsy tests will expand rapidly over the forecast period.

  • Which liquid biopsy market segments-screening, therapy selection, or monitoring tests-will experience the highest revenue growth through 2028?
  • What type of liquid biopsy tests-circulating tumor DNA, circulating tumor cell, or exosome tests-will exhibit the highest growth?

Expansion in CMS reimbursement coverage of liquid biopsy testing, changes in section D Medicare reimbursement, and the continued rollout of Medicare value-based programs will drive liquid biopsy testing.

  • How will these changes implemented by the CMS affect the liquid biopsy market?
  • Which liquid biopsy segments will be most affected?

Advancements in liquid biopsy technology-particularly the types of substrates chosen to be isolated and analyzed-continue to drive innovation in the market and differentiate new entrants.

  • Given the unique nature of every type of substrate, what are the advantages and disadvantages of each substrate within each liquid biopsy segment?
  • How will advancements in liquid biopsy tests affect the competitive positions of new entrants and the cannibalization of existing products?

Given the nascent nature of the liquid biopsy market, the pace of market expansion going forward will be contingent upon regulatory approvals, consistent research and development funding, and the emergence of favorable clinical data.

  • What are the baseline, optimistic, and pessimistic forecast scenarios for the liquid biopsy market given variable regulatory and research and development factors?

Table of Contents

United States

Abstract

Executive Summary

  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • Products Covered

Key Report Updates

Liquid Biopsy Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Share Rankings
  • Competitive Factors and Strategies
    • Clinical Data
    • Product Improvement and Innovations
    • Mergers, Acquisitions, and Partnerships
    • Product Portfolio Management
  • Market Developments

Screening Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Share Rankings
  • Competitive Factors and Strategies

Therapy Selection Test Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Share Rankings
  • Competitive Factors and Strategies
  • Monitoring Test Market
  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Share Rankings
  • Competitive Factors and Strategies

Appendix

  • Abbreviations
  • Bibliography